DS
EW icon

DRW Securities’s Edwards Lifesciences EW Stock Holding History

DRW Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,543
Closed -$217K – 1431
2025
Q4 		$217K Sell
2,543
-676
-21% -$55.5K 0.01% 912
2025
Q3 		$250K Sell
3,219
-717
-18% -$56K ﹤0.01% 952
2025
Q2 		$299K Buy
+3,936
New +$294K 0.01% 737
2024
Q2 		– Sell
-3,146
Closed -$279K – 559
2024
Q1 		$301K Buy
+3,146
New +$264K 0.01% 279
2020
Q1 		– Sell
-4,902
Closed -$381K – 311
2019
Q4 		$381K Buy
+4,902
New +$383K 0.01% 144
2018
Q1 		– Sell
-8,928
Closed -$335K – 277
2017
Q4 		$335K Buy
+8,928
New +$328K 0.04% 296

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

DRW Securities's EW Position: Q1 2026 in Review

DRW Securities sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,543 shares — an estimated $217K sold.

DRW Securities first reported a position in EW in Q4 2017 and held it in 6 quarters. The position peaked at $381K in Q4 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • DRW Securities reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 2,543 Edwards Lifesciences shares in Q1 2026, an estimated $217K.
  • DRW Securities first reported a position in Edwards Lifesciences in Q4 2017 and held it in 6 quarters.
  • DRW Securities's Edwards Lifesciences position peaked at $381K in Q4 2019.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.